Volume 28, Issue 3 (October 2021)                   J Birjand Univ Med Sci 2021, 28(3): 302-306 | Back to browse issues page

Research code: .
Ethics code: .
Clinical trials code: .

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bagheri Sheykhangafshe F, Fathi-Ashtiani A. Priority of the elderly and patients with chronic diseases in COVID-19 vaccination: Letter to Editor. J Birjand Univ Med Sci. 2021; 28 (3) :302-306
URL: http://journal.bums.ac.ir/article-1-3007-en.html
1- PhD Candidate in Psychology, Faculty of Humanities, Tarbiat Modares University, Tehran, Iran
2- Professor, Behavioral Sciences Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran , afa1337@gmail.com
Abstract:   (1016 Views)
From the earliest days of coronavirus 2019 (COVID-19) outbreaks, all countries have been trying to develop vaccines and medications to fight the virus. Finally, a year after the COVID-2019 pandemic, several companies developed vaccines that were safe against this disease. However, the lack of doses of these vaccines created problems for various countries. Ethically, some groups should be highly prioritized according to their need and necessity of receiving the vaccine. Based on the results of current studies, safe and effective vaccination can be effective for the elderly and patients with chronic diseases and prevent the death of such people extensively. Since the national vaccination in Iran has started on February 12, 2021, with the priority of the medical staff, it is necessary to pay more attention to the elderly and patients with chronic diseases in future planning regarding the COVID-19 vaccination.
Full-Text [PDF 303 kb]   (403 Downloads) |   |   Full-Text (HTML)  (145 Views)  
Type of Study: Letter to the Editor | Subject: Clinical Psychology
Received: 2021/04/18 | Accepted: 2021/07/14 | ePublished ahead of print: 2021/07/25 | ePublished: 2021/09/18

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Birjand University of Medical Sciences

Designed & Developed by : Yektaweb